Results 241 to 250 of about 41,583 (267)
Some of the next articles are maybe not open access.

Vascular endothelial growth factors and angiogenesis.

Annales d'endocrinologie, 2000
VEGF was discovered in 1989. Research -conducted over the past 10 years has -demonstrated that VEGF is a major regulator of angiogenesis and vasculogenesis. This paper reviews the molecular data on the multiple forms of VEGF, their signalling and accessory receptors. Five genes encoding VEGF-like proteins have been identified; the different isoforms of
Frelin, C., Ladoux, A., D'Angelo, Gisela
openaire   +2 more sources

Growth Factors for Vascular Endothelial Cells

1990
The search for the molecular mediators of growth control in vascular endothelial cells has led to the discovery of a family of endothelial cell growth factors (ECGFs) which differ widely in their ability to trigger endothelial cell proliferation and differentiation in an in vitro or in vivo context.
openaire   +2 more sources

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Vascular Endothelial Growth Factor (VEGF)

2016
One of the best-validated signalling pathways in angiogenesis is vascular endothelial growth factor (VEGF) and its receptors. VEGF family encompasses 7 VEGF glycoproteins members including, VEGF-A, VEGF-B, VEGF-C, VEGF-D, and VEGF-E and placental growth factors 1 and 2 (PLGF). Of these, the very well-characterized member is VEGF-A. Vascular endothelial
openaire   +2 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel   +2 more
exaly  

Vascular Endothelial Growth Factors

2002
Shun-ichi Harada, Kenneth A. Thomas
openaire   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Ciara C O’sullivan   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Barata, Brian I Rini
exaly  

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Ca-A Cancer Journal for Clinicians, 2018
Farhad Islami   +2 more
exaly  

Home - About - Disclaimer - Privacy